Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rory Collins

Showing results (101-110 of 267) with videos related to

Pageof 27
Sort By:
European Heart Journal|October 4, 2023
Mechanisms of rosuvastatin-related acute kidney injury following cardiac surgery: the STICS trialRohan S Wijesurendra, Rebecca Sardell, Raja Jayaram, et al.
Wellcome Open Research|January 18, 2021
Approaches to minimising the epidemiological impact of sources of systematic and random variation that may affect biochemistry assay data in UK BiobankNaomi E Allen, Matthew Arnold, Sarah Parish, et al.
JAMA|September 20, 2007
Association of apolipoprotein E genotypes with lipid levels and coronary riskAnna M Bennet, Emanuele Di Angelantonio, Zheng Ye, et al.
JAMA|July 23, 2009
Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality, Sebhat Erqou, Stephen Kaptoge, et al.
The New England Journal of Medicine|August 30, 2017
Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease, Louise Bowman, Jemma C Hopewell, et al.
Plos One|January 26, 2012
Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy, Jonathan R Emberson, Patricia M Kearney, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 12, 2022
Weight loss in a cardiovascular trial population identifies people at future risk of dementiaPieter van der Veere, Imen Hammami, Georgina Buck, et al.
Lancet (London, England)|June 2, 2009
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials, Colin Baigent, Lisa Blackwell, et al.
JAMA Network Open|March 2, 2019
Assessment of Vascular Event Prevention and Cognitive Function Among Older Adults With Preexisting Vascular Disease or Diabetes: A Secondary Analysis of 3 Randomized Clinical TrialsAlison Offer, Matthew Arnold, Robert Clarke, et al.
Circulation. Genomic and Precision Medicine|February 17, 2018
Impact of Apolipoprotein(a) Isoform Size on Lipoprotein(a) Lowering in the HPS2-THRIVE StudySarah Parish, Jemma C Hopewell, Michael R Hill, et al.
Pageof 27

Showing results (101-110 of 267) with videos related to

Sort By:
Pageof 27
European Heart Journal|October 4, 2023
Mechanisms of rosuvastatin-related acute kidney injury following cardiac surgery: the STICS trialRohan S Wijesurendra, Rebecca Sardell, Raja Jayaram, et al.
Wellcome Open Research|January 18, 2021
Approaches to minimising the epidemiological impact of sources of systematic and random variation that may affect biochemistry assay data in UK BiobankNaomi E Allen, Matthew Arnold, Sarah Parish, et al.
JAMA|September 20, 2007
Association of apolipoprotein E genotypes with lipid levels and coronary riskAnna M Bennet, Emanuele Di Angelantonio, Zheng Ye, et al.
JAMA|July 23, 2009
Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality, Sebhat Erqou, Stephen Kaptoge, et al.
The New England Journal of Medicine|August 30, 2017
Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease, Louise Bowman, Jemma C Hopewell, et al.
Plos One|January 26, 2012
Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy, Jonathan R Emberson, Patricia M Kearney, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 12, 2022
Weight loss in a cardiovascular trial population identifies people at future risk of dementiaPieter van der Veere, Imen Hammami, Georgina Buck, et al.
Lancet (London, England)|June 2, 2009
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials, Colin Baigent, Lisa Blackwell, et al.
JAMA Network Open|March 2, 2019
Assessment of Vascular Event Prevention and Cognitive Function Among Older Adults With Preexisting Vascular Disease or Diabetes: A Secondary Analysis of 3 Randomized Clinical TrialsAlison Offer, Matthew Arnold, Robert Clarke, et al.
Circulation. Genomic and Precision Medicine|February 17, 2018
Impact of Apolipoprotein(a) Isoform Size on Lipoprotein(a) Lowering in the HPS2-THRIVE StudySarah Parish, Jemma C Hopewell, Michael R Hill, et al.
Pageof 27